Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status  Phase of research How it helps Latest publication
Moxifloxacin
Potential treatment - clinical evidence Used to treat other disease Other treatment Jun/05/2020
Acetylsalicylic acid
Potential treatment - clinical evidence Used to treat other disease Other treatment May/23/2021
Emtricitabine
Potential treatment - clinical evidence Used to treat other disease Antiviral Dec/20/2021
Tenofovir
Potential treatment - clinical evidence Used to treat other disease Antiviral Dec/20/2021
Fluvoxamine
Potential treatment - clinical evidence Used to treat other disease Other treatment Oct/27/2021
Metformin
Potential treatment - clinical evidence Used to treat other disease Other treatment Dec/14/2021
IVIg
Potential treatment - clinical evidence Used to treat other disease Other treatment May/23/2021
Itolizumab
Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/29/2021
Ozone
Potential treatment - clinical evidence Used to treat other disease Other treatment Mar/22/2021
Metformin glycinate
Potential treatment - clinical evidence Used to treat other disease Other treatment
Sitagliptin
Potential treatment - clinical evidence Used to treat other disease Other treatment
Angiotensin-converting enzyme inhibitors
Potential treatment - clinical evidence Used to treat other disease Other treatment
Angiotensin receptor blockers
Potential treatment - clinical evidence Used to treat other disease Other treatment
Dipeptidyl peptidase-4 inhibitor
Potential treatment - clinical evidence Used to treat other disease Other treatment
Cobimetinib
Potential treatment - pre-clinical evidence Used to treat other disease Other treatment Sep/06/2021
Ponatinib
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Sep/06/2021
Bortezomib
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/12/2021
Lurasidone
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/10/2021
Elbasvir
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/10/2021
Suramin
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/05/2021